Moors & Cabot’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-2,010
Closed -$250K 885
2021
Q2
$250K Buy
2,010
+41
+2% +$4.89K 0.02% 644
2021
Q1
$259K Sell
1,969
-2,200
-53% -$301K 0.02% 587
2020
Q4
$549K Sell
4,169
-1,391
-25% -$168K 0.05% 344
2020
Q3
$567K Buy
+5,560
New +$480K 0.05% 307
2020
Q1
Sell
-4,535
Closed -$418K 632
2019
Q4
$418K Buy
4,535
+1,385
+44% +$122K 0.04% 388
2019
Q3
$284K Buy
3,150
+1,325
+73% +$151K 0.03% 466
2019
Q2
$215K Buy
+1,825
New +$184K 0.03% 494
2019
Q1
Sell
-5,200
Closed -$328K 533
2018
Q4
$328K Sell
5,200
-200
-4% -$13.7K 0.05% 344
2018
Q3
$426K Sell
5,400
-300
-5% -$19.6K 0.05% 349
2018
Q2
$342K Buy
+5,700
New +$307K 0.05% 390
2018
Q1
Sell
-4,501
Closed -$237K 588
2017
Q4
$237K Buy
+4,501
New +$240K 0.03% 469
2016
Q2
Sell
-10,650
Closed -$72K 524
2016
Q1
$72K Buy
10,650
+375
+4% +$2.4K 0.01% 493
2015
Q4
$94K Buy
+10,275
New +$95.5K 0.02% 473

Other funds holding EXAS

Moors & Cabot's EXAS Position: Q3 2021 in Review

Moors & Cabot sold out of Exact Sciences (EXAS) in Q3 2021, closing a stake of 2,010 shares — an estimated $250K sold.

Moors & Cabot first reported a position in EXAS in Q4 2015 and held it in 13 quarters. The position peaked at $567K in Q3 2020. 601 funds tracked by Wall St. Rank hold EXAS as of Q3 2021.

  • Moors & Cabot reported no remaining Exact Sciences position as of Q3 2021 after selling out during the quarter.
  • Moors & Cabot sold 2,010 Exact Sciences shares in Q3 2021, an estimated $250K.
  • Moors & Cabot first reported a position in Exact Sciences in Q4 2015 and held it in 13 quarters.
  • Moors & Cabot's Exact Sciences position peaked at $567K in Q3 2020.
  • 601 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2021.

Based on Moors & Cabot's 13F filing for Q3 2021, filed 5 Nov 2021.